Enhancing head and neck tumor management with artificial intelligence: Integration and perspectives

NN Zhong, HQ Wang, XY Huang, ZZ Li, LM Cao… - Seminars in Cancer …, 2023 - Elsevier
Head and neck tumors (HNTs) constitute a multifaceted ensemble of pathologies that
primarily involve regions such as the oral cavity, pharynx, and nasal cavity. The intricate …

Emerging histological and serological biomarkers in oral squamous cell carcinoma: Applications in diagnosis, prognosis evaluation and personalized therapeutics

L Pekarek, MJ Garrido-Gil… - Oncology …, 2023 - spandidos-publications.com
Oral squamous cell carcinoma (OSCC) is the most common malignancy of the oral cavity
and accounts for> 90% of all oral cancers. Despite advances in diagnostic procedures and …

Immunotherapy in head and neck cancer: where do we stand?

NG Vallianou, A Evangelopoulos, D Kounatidis… - Current Oncology …, 2023 - Springer
Abstract Purposeof Review Head and neck cancer (HNC) comprises a group of
malignancies, amongst which squamous cell carcinoma accounts for more than 90% of the …

Current insights and progress in the clinical management of head and neck cancer

MN Amaral, P Faísca, HA Ferreira, MM Gaspar… - Cancers, 2022 - mdpi.com
Simple Summary Head and neck cancer (HNC) incidence has been steadily increasing
since the 1990s. While the multimodal treatment approach for localized HNC is well …

Tumor pH-functionalized and charge-tunable nanoparticles for the nucleus/cytoplasm-directed delivery of oxaliplatin and miRNA in the treatment of head and neck …

YL Lo, HC Lin, WH Tseng - Acta Biomaterialia, 2022 - Elsevier
Prospective tumor pH-responsive and charge-convertible nanoparticles have been utilized
to reduce side effects and improve the active tumor-targeting ability and nuclear/cytoplasmic …

The role of different immunocompetent cell populations in the pathogenesis of head and neck cancer—regulatory mechanisms of pro-and anti-cancer activity and their …

K Starska-Kowarska - Cancers, 2023 - mdpi.com
Simple Summary According to the latest GLOBOCAN data, head and neck squamous cell
carcinoma (HNSCC) represents the sixth most prevalent human malignancy. Recent studies …

[HTML][HTML] Impact of adjuvant radiochemotherapy on free flap volume in head and neck reconstruction: A systematic review and meta-analysis

P Pfister, NE Speck, B Gahl, L Muller, T Fürst… - Journal of Plastic …, 2024 - Elsevier
Background Limited data exists regarding the effect of adjuvant radiochemotherapy on free
flap volume in head and neck reconstruction. However, an adequate free flap volume is an …

[HTML][HTML] The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers

S Mestiri, DMA El-Ella, Q Fernandes, T Bedhiafi… - Biomedicine & …, 2024 - Elsevier
Head and neck cancer (HNC) is the sixth most common cancer type, accounting for
approximately 277,597 deaths worldwide. Recently, the Food and Drug Administration …

Localized Drug Delivery Systems: An Update on Treatment Options for Head and Neck Squamous Cell Carcinomas

A Hariharan, SD Tran - Pharmaceutics, 2023 - mdpi.com
Head and neck squamous cell carcinoma (HNSCC) is one of the most common cancers in
the world, with surgery, radiotherapy, chemotherapy, and immunotherapy being the primary …

Anti-cancer management of head and neck cancers and oral microbiome—what can we clinically obtain?

J Makarewicz, K Kaźmierczak-Siedlecka… - Frontiers in Cellular …, 2024 - frontiersin.org
Head and neck squamous cell carcinoma (HNSCC) exhibits significant genetic
heterogeneity and primarily concerns the oral cavity and oropharynx. These cancers occur …